Abstract C39: First-in-class inhibitors of the putatively undruggable DNA repair target Poly(ADP-ribose) glycohydrolase (PARG)Bohdan Waszkowycz, Donald Ogilvie, Ben Acton et al.|Molecular Cancer Therapeutics|2015Cited by 0